Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Small. 2019 Sep 29;15(46):e1903747. doi: 10.1002/smll.201903747

Figure 3. Differential tumor uptake of 64Cu-NOTA-UPSN in different TNBC models.

Figure 3.

(A) Whole body MIP from longitudinal PET scans of 4T1 (top panel) and MDA-MB 231 (lower panel) tumor-bearing mice after i.v. injection of 64Cu-NOTA-UPSN. Green arrows indicate the tumors. TACs obtained from in vivo ROI analysis of (B) 4T1 and (C) MDA-MB 231 tumor-bearing mice. (D, E) TACs derived from modeling of the observed data. Data represents mean ± SD (n = 4).